CONTENT VALIDATION AND DISCLOSURES
Research To Practice is committed to providing its participants with high-quality, unbiased and state-of-the-art education. We assess potential conflicts of interest with faculty, planners and managers of CME activities. Real or apparent conflicts of interest are identified and resolved through a conflict of interest resolution process. In addition, all activity content is reviewed by both a member of the Research To Practice scientific staff and an external, independent reviewer for fair balance, scientific objectivity of studies referenced and patient care recommendations.
FACULTY — The following faculty (and their spouses/partners) reported real or apparent conflicts of interest, which have been resolved through a conflict of interest resolution process: Dr Lacouture — Consulting Agreement: Onyx Pharmaceuticals Inc; Paid Research: GlaxoSmithKline, Hana Biosciences Inc; Paid Speaker: Bristol-Myers Squibb Company; Speakers Bureau: ImClone Systems Incorporated. Dr LoRusso — Consultant/Advisory Board: AstraZeneca Pharmaceuticals LP, Genentech BioOncology, Pfizer Inc, Takeda Pharmaceuticals North America Inc; Grant/Research Support: Amgen Inc, Array BioPharma Inc, ARIAD Pharmaceuticals Inc, AstraZeneca Pharmaceuticals LP, Boehringer Ingelheim GmbH, Bristol-Myers Squibb Company, Endocyte Inc, Exelixis Inc, Genentech BioOncology, GlaxoSmithKline, ImClone Systems Incorporated, Merck and Company Inc, Nereus Pharmaceuticals Inc, Novartis Pharmaceuticals Corporation, Pfizer Inc, Roche Laboratories Inc, Sanofi-Aventis, ZIOPHARM Oncology Inc; Speakers Bureau: Genentech BioOncology, GlaxoSmithKline, Sanofi-Aventis. Dr Natale — Advisory Committee: AstraZeneca Pharmaceuticals LP, Eli Lilly and Company, Genentech BioOncology, Pharmion Corporation, Roche Laboratories Inc; Consulting Agreement: Eli Lilly and Company; Paid Research: Amgen Inc, AstraZeneca Pharmaceuticals LP, Genentech BioOncology, Millennium Pharmaceuticals Inc, Pfizer Inc, Pharmion Corporation, Sanofi-Aventis; Speakers Bureau: Genentech BioOncology, OSI Pharmaceuticals Inc. Dr Riely — Consulting Agreements: Boehringer Ingelheim GmbH, Roche Laboratories Inc. Dr Sledge — Advisory Committee: Genentech BioOncology, GlaxoSmithKline, Novartis Pharmaceuticals Corporation; Consulting Agreement: Genentech BioOncology; Paid Research: Eli Lilly and Company, Sanofi-Aventis. Dr Venook — Advisory Committee: Amgen Inc, ImClone Systems Incorporated; Grant Funding: Genentech BioOncology; Paid Research: Novartis Pharmaceuticals Corporation, Pfizer Inc. Dr Vogelzang — Advisory Committee: Amgen Inc, Genentech BioOncology, GPC Biotech; Clinical Trials: Bayer Pharmaceuticals Corporation, Novartis Pharmaceuticals Corporation, Onyx Pharmaceuticals Inc; Consulting Agreements: Amgen Inc, Bristol-Myers Squibb Company, Eli Lilly and Company, Novartis Pharmaceuticals Corporation, Pfizer Inc, Sanofi-Aventis; Paid Research: Onyx Pharmaceuticals Inc; Speakers Bureau: Bayer Pharmaceuticals Corporation, Pfizer Inc, Sanofi-Aventis, Schering-Plough Corporation, Wyeth.
RESEARCH TO PRACTICE STAFF AND EXTERNAL REVIEWERS — The scientific staff and reviewers for Research To Practice have no real or apparent conflicts of interest to disclose.
This educational activity contains discussion of published and/or investigational uses of agents that are not indicated by the Food and Drug Administration. Research To Practice does not recommend the use of any agent outside of the labeled indications. Please refer to the official prescribing information for each product for discussion of approved indications, contraindications and warnings. The opinions expressed are those of the presenters and are not to be construed as those of the publisher or grantor.
